Total phenolic content, antioxidant activity and In vitro inhibitory potential against key enzymes relevant for hyperglycemia of Bridelia ferruginea extracts

Research Journal of Phytochemistry

Volumn 6, Issue 4, 2012, Pages 120-126

  Bakoma, Batomayena ^a,b   Berké, Bénédicte ^b   Eklu Gadegbeku, Kwashie ^a   Diallo, Aboudoulatif ^a   Agbonon, Amegnona ^a   Aklikokou, Kodjo ^a   Gbeassor, Messanvi ^a   Moore, Nicholas ^b  

^a UNIVERSITY OF LOMÉ   (Togo)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Glucosidase a amylase inhibitor; Antioxidant activity; Bridelia ferruginea; Phenolic phytochemicals

Indexed keywords

BRIDELIA FERRUGINEA;

EID: 84871778692     PISSN: 18193471     EISSN: 21516081     Source Type: Journal    
DOI: 10.3923/rjphyto.2012.120.126     Document Type: Article

References (23)

1. American Diabetes Association, 2005. Diagnosis and classification of diabetes mellitus. Diabetes Care, 28: S37-S42.
2. Bakoma, B., K. Eklu-Gadegkeku, A. Agbonon, K. Aklikokou, E. Bassene and M. Gbeassor, 2011. Preventive effect of Bridelia ferruginea against high-fructose diet induced glucose intolerance, oxidative stress and hyperlipidemia in male Wistar rats. J. Pharmacol. Toxicol., 6: 249-257.
3. Bhandari, M.R., N. Jong-Anurakkun, G. Hong and J. Kawabata, 2008. α-glucosidase and a-amylase inhibitory activities of Nepalese medicinal herb. Food Chem., 106: 247-252.
4. Bischoff, H., W. Puis, H.P. Krause, H. Schutt and G. Thomas, 1985. Pharmacological properties of the novel glucosidase inhibitors BAY ml099 (miglitol) and BAY 1248. Diabetes Res. Clin. Pract., 1: 53-62.
5. Brownlee, M., 2005. The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54: 1615-1625.
6. Chang, A.M., M.J. Smith, C.J. Bloem, A.T. Galecki and J.B. Halter, 2004. Effect of lowing postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance. Am. J. Physiol. Endocrinol. Metab., 287: E906-E911.
7. De Melo, E.B., A.D.S. Gomes and I. Carvalho, 2006. α- and β-Glucosidase inhibitors: Chemical structure and biological activity. Tetrahedron, 62: 10277-10302.
8. DeFronzo, R.A., 1999. Pharmacologic therapy for type 2 diabetes mellitus. Ann. Int. Med., 131:281-303.
9. Dicarli, M.F., J. Janises, J. Ager and G. Grunberger, 2003. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J. Am. Coll. Cardiol., 41: 1387-1393.
10. Gray, G.M., 1995. Carbohydrate digestion and absorption-role of small intestine. N. Engl. J. Med., 29: 1225-1230.
11. Hamdan, I.I. and F.U. Afifi, 2004. Studies on the in vitro and in vivo hypoglycemic activities of some medicinal plants used in treatment of diabetes in Jordanian traditional medicine. J. Ethnopharmacol., 93: 117-121.
12. IDF, 2011. The Globlal Burden. 5th Edn, IDF Diabetes Atlas, United States.
13. Janovik, V., A.A. Bohgon, R.V. Bandeira and M.L. Athayde, 2011. HPLC/DAD analysis, determination of total phenolic and flavonoid contents and antioxidant activity from the leaves of Cariniana domestica (Mart) Miers. Res. J. Phytochem., 5: 209-215.
14. Klepser, T.B. and M.E. Klepser, 1999. Unsafe and potentially safe herbal therapies. Am. J. Health. Syst. Pharm, 56: 125-138.
15. Kwon, Y.I., E. Apostolidis and K. Shetty, 2008. In vitro studies of eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension. Bioresour. Technol, 99:2981-2988.
16. Puis, W., U. Keup, H. Krause, P.G. Thomas and F. Hoffmeister, 1977. Glucosidase inhibition: A new approach to the treatment of diabetes, obesity and hyperlipoproteinemia. Naturwissens-Chaften, 64: 536-537.
17. Ranilla, L.G., Y.I. Kwon, E. Apostolidis and K. Shetty, 2010. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresource Technol., 101: 4676-4689.
18. Ratner, R.E., 2001. Controlling postprandial hyperglycemia. Am. J. Cardiol., 88: 26-31.
19. Shetty, K., O.F. Curtis, R.E. Levin, R. Wikowsky and W. Aug, 1995. Prevention of verification associated with in vitro shoot culture of oregano (Origanum vulgare) by Pseudomonas spp. J. Plant Physiol, 147: 447-451.
20. Shobana, S, Y.N. Sreerama and N.G. Malleshi, 2009. Composition and enzyme inhibitory properties of finger millet (Eleusine coracana L.) seed coat phenolics: Mode of inhibition of a-glucosidase and pancreatic amylase. Food Chem, 115: 1268-1273.
21. Song, Y, J.E. Manson, J.E. Buring, D. Howard and S. Liu, 2005. Associations of dietary flavonoids with risk of type 2 diabetes and markers of insulin resistance and systemic inflammation in women: A prospective study and cross-sectional analysis. J. Am. Coll. Nutr, 24: 376-384.
22. WHO, 1999. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of Word Health Organization Consultation. Geneva, Switzerland, pp: 66.
23. Wang, J, B. Sun, Y. Cao and Y. Tian, 2009. Protection of wheat bran feruloyl oligosaccharides against free radical-induced oxidative damage in normal human erythrocytes. Food Chem. Toxicol, 47: 1591-1599.